Literature DB >> 12218971

Mechanism of failure in the treatment of type II endoleak with percutaneous coil embolization.

Maurice M Solis1, Juan Ayerdi, Gregory A Babcock, Jose R Parra, Robert B McLafferty, Laura A Gruneiro, Don E Ramsey, Kim J Hodgson.   

Abstract

PURPOSE: Type II endoleak after endovascular abdominal aortic aneurysm repair is a failure of aneurysm sac exclusion with unknown long-term consequences. Elevated aneurysm sac pressures documented in these patients have led us to aggressively treat type II endoleaks with percutaneous transluminal coil embolization (PTCE). The purpose of this study was to evaluate the results and the mechanisms of failure of PTCE for type II endoleak.
METHODS: One hundred ninety-one patients underwent endograft repair of infrarenal aortic aneurysms. Twenty-three of 28 patients with persistent primary (>3 months) or secondary (new-onset) endoleak underwent angiography; 14 of these patients had type II endoleaks. We reviewed our endovascular registry data, hospital charts, and radiologic studies of patients with type II endoleaks and analyzed the results in those treated with PTCE of the inflow vessel.
RESULTS: All 14 patients with type II endoleaks were men, with a mean age of 76.7 years and a mean preoperative maximal aneurysm diameter of 5.7 +/- 1.0 cm. The type II endoleak was primary in 12 patients (86%) and secondary in two patients (14%) and iliolumbar in 11 patients (78%) and mesenteric in three patients (21%). Although a dominant affluent collateral channel (inosculation) was apparent in eight patients (57%), six patients (43%) showed a network of collateral vessels (retiform anastomosis). In six patients (43%), angiography revealed a second or "outflow" vessel indicative of a complex endoleak. In four patients with retiform iliolumbar type II endoleaks, PTCE was not attempted because of the retiform nature of the endoleak. The remaining 10 patients underwent PTCE, with coil deployment in all 10 and apparent initial technical success in nine patients. Follow-up computed tomographic scans revealed persistent endoleaks in six patients (60%). Mechanisms of failure included persistent flow through the coils in the treated vessel in two patients, development of a retiform anastomosis around the coiled vessel in three patients, and development of a new mesenteric endoleak after successful occlusion of an iliolumbar endoleak in one patient. Two patients underwent repeat PTCE with successful aneurysm sac exclusion in one. Internal iliac artery injury complicated one of the 12 PTCEs, and the resulting pseudoaneurysm was successfully treated with PTCE. Angiographic visualization of an outflow vessel (complex endoleak) was associated with PTCE failure (P =.008).
CONCLUSION: PTCE of type II endoleaks has a high failure rate because of multiple anatomic mechanisms.

Entities:  

Mesh:

Year:  2002        PMID: 12218971     DOI: 10.1067/mva.2002.126542

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  16 in total

1.  Iatrogenic Ureteral Injury during Translumbar Embolization of a Type II Endoleak.

Authors:  Charles T Burke
Journal:  Semin Intervent Radiol       Date:  2007-09       Impact factor: 1.513

2.  Risk factors for a persistent type 2 endoleak after endovascular aneurysm repair.

Authors:  Toshiyuki Maeda; Toshiro Ito; Yoshihiko Kurimoto; Toshitaka Watanabe; Yohsuke Kuroda; Nobuyoshi Kawaharada; Tetsuya Higami
Journal:  Surg Today       Date:  2014-11-12       Impact factor: 2.549

3.  Case report. A novel approach to the management of a ruptured Type II endoleak following endovascular repair of an internal iliac artery aneurysm.

Authors:  S D Patel; A Perera; N Law; S Mandumula
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

4.  CT Findings of Risk Factors for Persistent Type II Endoleak from Inferior Mesenteric Artery to Determine Indicators of Preoperative IMA Embolization.

Authors:  Tetsuya Fukuda; Hitoshi Matsuda; Yoshihiro Sanda; Yoshiaki Morita; Kenji Minatoya; Junjiro Kobayashi; Hiroaki Naito
Journal:  Ann Vasc Dis       Date:  2014-08-30

5.  Transcaval embolization as an alternative technique for the treatment of type II endoleak after endovascular aortic aneurysm repair.

Authors:  Salvatore T Scali; Adrian Vlada; Catherine K Chang; Adam W Beck
Journal:  J Vasc Surg       Date:  2013-01-09       Impact factor: 4.268

Review 6.  Predictive Factors for the Development of Type 2 Endoleak Following Endovascular Aneurysm Repair.

Authors:  Paul J O'Connor; Robert A Lookstein
Journal:  Semin Intervent Radiol       Date:  2015-09       Impact factor: 1.513

7.  Endovascular stent graft repair of abdominal and thoracic aortic aneurysms: a ten-year experience with 817 patients.

Authors:  Michael L Marin; Larry H Hollier; Sharif H Ellozy; David Spielvogel; Harold Mitty; Randall Griepp; Robert A Lookstein; Alfio Carroccio; Nicholas J Morrissey; Victoria J Teodorescu; Tikva S Jacobs; Michael E Minor; Claudie M Sheahan; Kristina Chae; Juliana Oak; Andrew Cha
Journal:  Ann Surg       Date:  2003-10       Impact factor: 12.969

8.  Late Sac Behavior after Endovascular Aneurysm Repair for Abdominal Aortic Aneurysm.

Authors:  Masahiro Okada; Nobuhiro Handa; Toshihiro Onohara; Minoru Okamoto; Tsuyoshi Yamamoto; Yasushi Shimoe; Masafumi Yamashita; Toshiki Takahashi; Jyunji Kishimoto; Akihiro Mizuno; Junichi Kei; Mikizou Nakai; Masayuki Sakaki; Hitoshi Suhara; Fuminori Kasashima; Masamitsu Endo; Takeshi Nishina; Tadashi Furuyama; Masakazu Kawasaki; Keiji Iwata; Akira Marumoto; Yasuhisa Urata; Katsutoshi Sato; Masahiro Ryugo
Journal:  Ann Vasc Dis       Date:  2016-06-02

9.  Laparoscopic transperitoneal clipping of the inferior mesenteric artery for the management of type II endoleak after endovascular repair of an aneurysm.

Authors:  P Ho; W L Law; P H M Tung; J T C Poon; A C W Ting; S W K Cheng
Journal:  Surg Endosc       Date:  2004-05       Impact factor: 4.584

10.  Endoleak following endovascular abdominal aortic aneurysm repair: implications for duration of screening.

Authors:  Matthew A Corriere; Irene D Feurer; Stacey Y Becker; Jeffery B Dattilo; Marc A Passman; Raul J Guzman; Thomas C Naslund
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.